Keebeck Alpha, LP Cerus Corp Transaction History

Keebeck Alpha, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 01, 2023	SELL	$4.41 - $5.69 $66,445 - $85,731	-15,067 Reduced 59.92%	10,079 $53,000
Q2 2022 Aug 08, 2022	SELL	$4.41 - $5.69 $66,445 - $85,731	-15,067 Reduced 59.92%	10,079 $53,000
Q1 2022 Feb 01, 2023	BUY	$4.81 - $6.99 $120,952 - $175,770	25,146 New	25,146 $138,000
Q1 2022 May 10, 2022	BUY	$4.81 - $6.99 $43,145 - $62,700	8,970 Added 55.45%	25,146 $138,000
Q4 2021 Feb 09, 2022	BUY	$5.97 - $7.93 $96,570 - $128,275	16,176 New	16,176 $110,000
Q3 2021 Nov 09, 2021	SELL	$4.79 - $6.68 $116,761 - $162,831	-24,376 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$5.35 - $6.35 $130,411 - $154,787	24,376 New	24,376 $144,000
Q4 2020 Feb 05, 2021	SELL	$5.25 - $8.56 $169,554 - $276,453	-32,296 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$5.78 - $7.47 $186,670 - $241,251	32,296 New	32,296 $202,000

160

144M

22.5K

23.6K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $328M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.